DrAIStudio

Cancer Biology & Therapy call for papers

Current call-for-papers opportunities for Cancer Biology & Therapy. Ranking signals: Indexed (Active), JIF 4.6. Use the official publisher page to verify scope and submission rules.

Accepting CFPs for Cancer Biology & Therapy

Engineering T Cells: From Mechanism to Medicine

Deadline 2027-05-31Taylor & FrancisIndexed (Active)

Journal: Cancer Biology & Therapy

Chimeric antigen receptor (CAR)-T cell therapy has redefined cancer immunotherapy. By re-engineering a patient's own T cells to recognize tumor antigens, CAR-T has delivered deep, durable, and curative responses in B-cell malignancies, including relapsed or refractory leukemias, lymphomas, and multiple myeloma, where conventional therapies had failed. This success has motivated efforts to improve the safety and effi…

Generate research ideas Open CFP source Submit

Reference integrity note: verify every citation against the original source before submission, including publication year, journal title, volume/issue, page range, DOI, and the target journal style.